The European Parliament adopted by 491 votes to 16, with 74 abstentions, a legislative resolution on the draft Council implementing decision on subjecting methyl 2-[[1-(cyclohexylmethyl)-1H-indole-3-carbonyl]amino]-3,3-dimethylbutanoate (MDMB-CHMICA) to control measures.
As a reminder, the Council draft aims to subject MDMB-CHMICA (classed as a synthetic cannabinoid receptor agonist) to control measures throughout the EU.
In line with its Committee on Civil Liberties, Justice and Home Affairs, Parliament approved the Council draft.